The newly proposed clinical and post-neoadjuvant treatment staging classifications for gastric adenocarcinoma for the American Joint Committee on Cancer (AJCC) staging Haejin InEthan RavetchTakeshi Sano Special Article 25 September 2017 Pages: 1 - 9
Prognostic significance of peritoneal lavage cytology in staging gastric cancer: systematic review and meta-analysis Sara JamelSheraz R. MarkarGeorge B. Hanna Review Article Open access 04 August 2017 Pages: 10 - 18
Short-term outcomes in minimally invasive versus open gastrectomy: the differences between East and West. A systematic review of the literature Nicole van der WielenJennifer StraatmanDonald L. van der Peet Review Article Open access 20 July 2017 Pages: 19 - 30
Tumor-associated macrophage infiltration is highly associated with PD-L1 expression in gastric adenocarcinoma Kazuto HaradaXiaochuan DongJaffer A. Ajani Original Article 11 August 2017 Pages: 31 - 40
MicroRNA-1 acts as a tumor suppressor microRNA by inhibiting angiogenesis-related growth factors in human gastric cancer Meng XieDafydd Alwyn DartJia-Fu Ji Original Article Open access 10 May 2017 Pages: 41 - 54
Importance of human peritoneal mesothelial cells in the progression, fibrosis, and control of gastric cancer: inhibition of growth and fibrosis by tranilast Hiroto SaitoSachio FushidaTetsuo Ohta Original Article Open access 24 May 2017 Pages: 55 - 67
A prospective multi-institutional validity study to evaluate the accuracy of clinical diagnosis of pathological stage III gastric cancer (JCOG1302A) Takeo FukagawaHitoshi Kataion behalf of the Stomach Cancer Study Group of the Japan Clinical Oncology Group Original Article 13 February 2017 Pages: 68 - 73
Evaluation of the American Joint Committee on Cancer 8th edition staging system for gastric cancer patients after preoperative therapy Naruhiko IkomaMariela BlumBrian D. Badgwell Original Article 22 June 2017 Pages: 74 - 83
Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G) Yuji MiuraYasutaka SukawaIchinosuke Hyodo Original Article 11 May 2017 Pages: 84 - 95
Anthracycline-based triplets do not improve the efficacy of platinum-fluoropyrimidine doublets in first-line treatment of advanced gastric cancer: real-world data from the AGAMEMON National Cancer Registry A. Carmona-BayonasP. Jiménez-FonsecaAGAMENON study group Original Article 09 April 2017 Pages: 96 - 105
Safety, pharmacokinetic, and clinical activity profiles of ramucirumab in combination with three platinum/fluoropyrimidine doublets in Japanese patients with chemotherapy-naïve metastatic gastric/gastroesophageal junction cancer Kohei ShitaraShigenori KadowakiKei Muro Original Article 30 June 2017 Pages: 106 - 113
A non-randomized confirmatory trial of an expanded indication for endoscopic submucosal dissection for intestinal-type gastric cancer (cT1a): the Japan Clinical Oncology Group study (JCOG0607) Noriaki HasuikeHiroyuki OnoGastrointestinal Endoscopy Group of Japan Clinical Oncology Group (JCOG-GIESG) Original Article 21 February 2017 Pages: 114 - 123
The value of diagnostic endoscopic submucosal dissection for patients with clinical submucosal invasive early gastric cancer Keiichi FujiyaKohei TakizawaMasanori Terashima Original Article 08 May 2017 Pages: 124 - 132
Long-term outcome of endoscopic submucosal dissection is comparable to that of surgery for early gastric cancer: a propensity-matched analysis Hye Kyung JeonGwang Ha KimTae Yong Jeon Original Article 10 April 2017 Pages: 133 - 143
Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001–2007) Hitoshi KataiTakashi IshikawaRegistration Committee of the Japanese Gastric Cancer Association Original Article 17 April 2017 Pages: 144 - 154
Long-term outcomes of laparoscopy-assisted distal gastrectomy with suprapancreatic nodal dissection for clinical stage I gastric cancer: a multicenter phase II trial (JCOG0703) Naoki HikiHitoshi KataiOn behalf of Stomach Cancer Study Group of Japan Clinical Oncology Group Original Article 16 January 2017 Pages: 155 - 161
Higher incidence of pancreatic fistula in laparoscopic gastrectomy. Real-world evidence from a nationwide prospective cohort study Naoki HikiMichitaka HondaSeigo Kitano Original Article 08 September 2017 Pages: 162 - 170
The comprehensive complication index (CCI) is a more sensitive complication index than the conventional Clavien–Dindo classification in radical gastric cancer surgery Tae-Han KimYun-Suhk SuhHan-Kwang Yang Original Article 08 June 2017 Pages: 171 - 181
